Anti-CD70 [LD70]
AB03947-30.11
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetCD70
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD70 [LD70]
- Delivery Days Customer9
- Application Supplier NoteThis antibody block the binding of CD70 to CD21. This blocking effect was tested using the scFv version and it was reported that it was capable of blocking the binding of recombinant CD70-Fc to CD21 coated on ELISA plates. This antibody was also reported to have inhibitory effect on the growth of breast cancer cells in vitro. The in vivo inhibitory activity of this antibody was tested in mice infected with breast cancer cells MDA-MB-231. It was further reported that this antibody could inhibit tumor growth in vivo (CN109021106).
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDLD70
- Gene ID970
- Target nameCD70
- Target descriptionCD70 molecule
- Target synonymsCD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A, CD70 antigen, CD27 ligand, Ki-24 antigen, surface antigen CD70, tumor necrosis factor ligand 8A, tumor necrosis factor ligand superfamily member 7
- Protein IDP32970
- Protein NameCD70 antigen
- Scientific DescriptionThis is a reformatted human scFv antibody, based on the original human scFv format, created for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203



